Position in KYMR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,252,034
+$3,281,974 QoQ
Shares Held
80,684
+12.6% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#77
of 273 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. KYMR ranks #30 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in KYMR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,252,034 | 80,684 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,970,060 | 71,678 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,625,974 | 72,304 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,198,191 | 74,173 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,100,971 | 71,058 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,913,929 | 69,928 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,581,036 | 64,157 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,948,469 | 62,296 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,926,369 | 64,535 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,307,158 | 57,392 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,362,186 | 53,503 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $745,415 | 53,627 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,233,275 | 53,644 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,894,157 | 63,927 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,528,051 | 61,220 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,311,141 | 60,227 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,080,744 | 54,888 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,532,322 | 36,208 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,141,327 | 33,727 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,953,281 | 33,253 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,336,514 | 27,557 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $443,625 | 11,416 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $650,442 | 10,491 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||